Showing results (641-650 of 1,361) with videos related to

Sort By:
Pageof 137
The Journal of Pharmacy and Pharmacology|February 22, 2017
Quality and stability of extemporaneous pyridoxal phosphate preparations used in the treatment of paediatric epilepsyAbeer H A Mohamed-Ahmed, Matthew P Wilson, Maedelyn Albuera, et al.
Nature Genetics|January 23, 1999
PIK3CA is implicated as an oncogene in ovarian cancerL Shayesteh, Y Lu, W L Kuo, et al.
Cancer Research|May 3, 2008
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumorsNorazizah Shafee, Christopher R Smith, Shuanzeng Wei, et al.
Trends in Cancer|March 25, 2025
Molecular and clinical insights into early-onset endometrial cancerZimeng Wu, Zhe Hu, Qinlan Li, et al.
Cancer Research|January 2, 2009
Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistanceNathan T Ihle, Robert Lemos, Peter Wipf, et al.
Cancer Cell|May 12, 2016
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female PatientsYuan Yuan, Lingxiang Liu, Hu Chen, et al.
Human Molecular Genetics|October 6, 2005
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunctionGuiqing Huang, Sheryl Krig, David Kowbel, et al.
The Journal of Biological Chemistry|March 15, 2003
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cellsAbdellah Mansouri, Lon D Ridgway, Anita L Korapati, et al.
Molecular Cancer Research : MCR|July 18, 2009
Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cellsTimothy T Li, Mistre Alemayehu, Adel I Aziziyeh, et al.
Oncogene|January 18, 2012
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibitionA Astanehe, M R Finkbeiner, M Krzywinski, et al.
Pageof 137